Peculiarities of extended gynecological examination data in women with recurrent vulvovaginal candidiasis
DOI:
https://doi.org/10.15574/HW.2024.171.70Keywords:
recurrent vulvovaginal candidiasis, gynecological examination, gynecological history, colposcopy, biopsy of the cervix, cytological and histological examinationAbstract
The aim of the study - to determine the features of extended gynecological examination in patients with recurrent vulvovaginal candidiasis (RVVC): data from gynecological history, examination, colposcopy, cytological and histological examination to increase the effectiveness of prevention of recurrences in these patients.
Materials and methods. A prospective study and clinical-statistical analysis of gynecological history, examination, colposcopy, cytological and histological examination in patients with RVVC was carried out. The main group (MG) consisted of 70 women of reproductive age with RVVC and 40 healthy women of reproductive age, who made up the control group (CG).
Results. The most frequent complaint was itching in the vagina - in 32 (45.7%) and itching in the area of the external genitalia, which bothered 29 (41.4%) patients; complaints of dysuric disorders in 19 (27.1%) patients became the reason for an earlier visit, usually to a urologist; dyspareunia occurred in 24 (34.3%) patients. Cervical ectopy with signs of exocervicitis and endocervicitis was found in 20 (28.6%) patients with RVVC; an atypical transformation zone was noted in 15 (21.4%) and was represented by an acetowhite epithelium with clear contours in the transformation zone in 37 (52.8%) p<0.05. At the same time, acetobilious epithelium with punctation was found in 19 (27.1%) patients, acetobilious epithelium with mosaic in 12 (17.1%), simultaneously with punctuation and mosaic in 6 (8.6%) patients. In CG, ectopy without signs of exo- and endocervicitis was observed in 7 (17.5%) patients. A rather high percentage of CIN attracts attention - in 37 (52.8%) of 70 women of MG: of them, CIN I - in 26 (37.1%) women, CIN II - in 9 (12.8%) patients, CIN III - in 2 (2.9%) patients.
Conclusions. Subjectively, RVVC was characterized by mild clinical symptoms, at the same time marked inflammatory changes in the lower parts of the genital tract with involvement in the pathological process of the cervix. Every third patient had dysuric disorders against the background of chronic inflammatory diseases of the pelvic organs, which are present in the anamnesis. In most patients, the long recurrent course of the disease was accompanied by psychosomatic disorders, emotional lability.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the author.
References
Bitew A, Abebaw Y. (2018). Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC women's health. 18(1): 1-10. https://doi.org/10.1186/s12905-018-0607-z; PMid:29902998 PMCid:PMC6003188
Brunham RC, Paavonen J. (2020). Reproductive system infections in women: lower genital tract syndromes. Pathogens and disease. 78(5): ftaa022. https://doi.org/10.1093/femspd/ftaa022; PMid:32463432
Castanheira CP, Sallas ML, Nunes RAL, Lorenzi NPC, Termini L. (2021). Microbiome and cervical cancer. Pathobiology. 88(2): 187-197. https://doi.org/10.1159/000511477; PMid:33227782
Davey DD. (2003). Cervical cytology classification and the Bethesda System. The Cancer Journal. 9(5): 327-334. https://doi.org/10.1097/00130404-200309000-00002; PMid:14690307
Farhan MA, Moharram AM, Salah T, Shaaban OM. (2019). Types of yeasts that cause vulvovaginal candidiasis in chronic users of corticosteroids. Medical mycology. 57(6): 681-687. https://doi.org/10.1093/mmy/myy117; PMid:30544194
Faria-Gonçalves P, Rolo J, Gaspar C, Oliveira AS, Pestana PG, Palmeira-de-Oliveira R et al. (2020). Recurrent vulvovaginal Candida spp isolates phenotypically express less virulence traits. Microbial Pathogenesis. 148: 104471. https://doi.org/10.1016/j.micpath.2020.104471; PMid:32871255
Hammad NM, El Badawy NE, Nasr AM, Ghramh HA, Al Kady LM. (2018). Mannose-binding lectin gene polymorphism and its association with susceptibility to recurrent vulvovaginal candidiasis. BioMed research international. 2018: 7648152. https://doi.org/10.1155/2018/7648152; PMid:29850562 PMCid:PMC5904809
Kravchenko ОV. (2021). Problemni pytannia diahnostyky ta likuvannia vulvovahinitiv zmishanoi bakterialno-kandydoznoi etiolohii. Reproductive Endocrinology. (57): 43-46. https://doi.org/10.18370/2309-4117.2021.57.43-46
Kurman RJ, Malkasian JrGD, Sedlis A, Solomon D. (1991). From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification. Obstetrics & Gynecology. 77(5): 779-782.
Li W, Liu Ll, Luo Zz, Han Cy, Wu Qh et al. (2020) Associations of sexually transmitted infections and bacterial vaginosis with abnormal cervical cytology: A cross-sectional survey with 9090 community women in China. PLOS ONE. 15(3): e0230712. https://doi.org/10.1371/journal.pone.0230712; PMid:32214342 PMCid:PMC7098628
Maraki S, Mavromanolaki VE, Stafylaki D, Nioti E, Hamilos G, Kasimati A. (2019). Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis. Mycoses. 62(8): 692-697. https://doi.org/10.1111/myc.12946; PMid:31132175
Mintser AP. (2018). Statisticheskie metodyi issledovaniya v klinicheskoy meditsine. Prakticheskaya meditsina. 3: 41-45.
Quaas J, Reich O, Tirri BF, Küppers V. (2013). Explanation and use of the colposcopy terminology of the IFCPC (International Federation for Cervical Pathology and Colposcopy) Rio 2011. Geburtshilfe und Frauenheilkunde. 73(09): 904-907. https://doi.org/10.1055/s-0033-1350824; PMid:24771940 PMCid:PMC3859163
Romanenko TH, Staselovych LIu, Sulimenko OM. (2020). Ratsionalna terapiia kandydoznoho vulvovahinitu pid chas vahitnosti. Reproductive Endocrinology. 3(53): 105-108.
Rosati D, Bruno M, Jaeger M, Ten Oever J, Netea MG. (2020). Recurrent vulvovaginal candidiasis: an immunological perspective. Microorganisms. 8(2): 144. https://doi.org/10.3390/microorganisms8020144; PMid:31972980 PMCid:PMC7074770
Russo R, Superti F, Karadja E, De Seta F. (2019). Randomised clinical trial in women with Recurrent Vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment. Mycoses. 62(4): 328-335. https://doi.org/10.1111/myc.12883; PMid:30565745
Saxon GDGC, Edwards A, Rautemaa-Richardson R, Owen C, Nathan B, Palmer B et al. (2020). British Association for Sexual Health and HIV national guideline for the management of vulvovaginal candidiasis (2019). International journal of STD & AIDS. 31(12): 1124-1144. https://doi.org/10.1177/0956462420943034; PMid:32883171
Shcherba O, Lastovetska L, Shako V. (2019). Osoblyvosti klinichnoho perebihu khronichnoho kandydozno-herpetychnoho vulvovahinitu. Zbirnyk naukovykh prats Asotsiatsii akusheriv-hinekolohiv Ukrainy. 2(44): 126-131.
Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS. (2020). 2020 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. International journal of STD & AIDS. 29(13): 1258-1272. https://doi.org/10.1177/0956462418785451; PMid:30049258
Sobel JD, Sobel R. (2018). Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species. Expert opinion on pharmacotherapy. 19(9): 971-977. https://doi.org/10.1080/14656566.2018.1476490; PMid:29932786
Swidsinski A, Guschin A, Tang Q, Dörffel Y, Verstraelen H, Tertychnyy A et al. (2019). Vulvovaginal candidiasis: histologic lesions are primarily polymicrobial and invasive and do not contain biofilms. American journal of obstetrics and gynecology. 220(1): 91-e1. https://doi.org/10.1016/j.ajog.2018.10.023; PMid:30595144
Van Riel SJ, Lardenoije CM, Oudhuis GJ, Cremers NA. (2021). Treating (Recurrent) Vulvovaginal Candidiasis with Medical-Grade Honey - Concepts and Practical Considerations. Journal of Fungi. 7(8): 664. https://doi.org/10.3390/jof7080664; PMid:34436203 PMCid:PMC8400673
Wu X, Zhang S, Xu X, Shen L, Xu B, Qu W et al. (2019). RAFT-derived polymethacrylates as a superior treatment for recurrent vulvovaginal candidiasis by targeting biotic biofilms and persister cells. Frontiers in microbiology. 10: 2592. https://doi.org/10.3389/fmicb.2019.02592; PMid:31787962 PMCid:PMC6853869
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ukrainian Journal Health of Woman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
